Pictet Asset Management (Switzerland)’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	$8.42M	Buy	393,399 +122,546	+45%	+$2.62M	0.01%	656
2023 Q1	$11M	Buy	270,853 +197,916	+271%	+$8M	0.01%	596
2022 Q4	$3.39M	Buy	72,937 +18,840	+35%	+$876K	﹤0.01%	824
2022 Q3	$2.81M	Buy	54,097 +24,468	+83%	+$1.27M	﹤0.01%	848
2022 Q2	$1.4M	Buy	+29,629	New	+$1.4M	﹤0.01%	989